About this episode

The episode discusses how pharma companies can leverage new technologies during a pivotal moment in the industry.

How should pharma companies respond to the current “hinge moment” where new technologies are enabling breakthroughs in drug discovery, manufacturing and customer engagement? Maria Whitman’s guest Alex Koehler, vice president and head of digital technology and innovation at Amgen, believes it’s time to be bold and move faster to capitalize on this opportunity. In this episode they discuss: How Amgen is using its Amgen India Center as an innovation hub to tackle key challengesHow AI and d...

People in this episode

Host: Maria Whitman

Guest: Alex Koehler

Topics covered

• pharmaceutical innovation
• digital technology
• drug discovery
• AI in pharma
• customer engagement
• manufacturing breakthroughs

Mentioned in this episode

Organizations: Amgen

Places: Amgen India Center

More episodes of Transforming Biopharma

• ‘Everything changes at the same time’: On conversational AI with Veeva’s Arno Sosna · July 9, 2026 · 56 min
• Cultivating resilience: Building a better supply chain with McKesson’s Ammie McAsey · July 23, 2025 · 47 min
• ‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases · June 23, 2025 · 51 min
• ‘We’re all tech leaders now’: A conversation with Salesforce’s Kyrsten Musich · May 6, 2025 · 54 min
• How CRM can help pharma break barriers and transform customer engagement · April 18, 2025 · 46 min
• Expanding access to cell and gene therapies with McKesson’s Joe DePinto · September 11, 2024 · 44 min

Explore listener stats, chart rankings, contacts and more on the Transforming Biopharma podcast page.